| scholarly article | Q13442814 |
| P50 | author | Manho Kim | Q55728067 |
| Soon-Tae Lee | Q79665386 | ||
| Kon Chu | Q86742155 | ||
| Keun-Hwa Jung | Q86742164 | ||
| Sang Kun Lee | Q86742178 | ||
| Wooseok Im | Q88614877 | ||
| Jae-Jun Ban | Q112059986 | ||
| P2093 | author name string | Mijung Lee | |
| P2860 | cites work | Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease | Q85224456 |
| Role of exosomes/microvesicles in the nervous system and use in emerging therapies | Q21129255 | ||
| Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? | Q21129257 | ||
| Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery | Q24305813 | ||
| Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity | Q24321699 | ||
| Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series | Q24537164 | ||
| Exosomes from human saliva as a source of microRNA biomarkers | Q24614806 | ||
| Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. | Q27340206 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes | Q28189644 | ||
| The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease | Q28305485 | ||
| Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice | Q29615357 | ||
| Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes | Q30533859 | ||
| Nonenzymatic template-directed RNA synthesis inside model protocells | Q33922191 | ||
| Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease | Q34009621 | ||
| Altered microRNA regulation in Huntington's disease models | Q34146968 | ||
| MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms | Q34562807 | ||
| Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. | Q34632614 | ||
| Proteomic profiling of exosomes: current perspectives | Q34823982 | ||
| Transcriptional abnormalities in Huntington disease | Q35113363 | ||
| MicroRNA-124 slows down the progression of Huntington's disease by promoting neurogenesis in the striatum. | Q35746332 | ||
| Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells | Q36512528 | ||
| Therapeutic Delivery of MicroRNA-29b by Cationic Lipoplexes for Lung Cancer | Q36832223 | ||
| Turning REST/NRSF dysfunction in Huntington's disease into a pharmaceutical target | Q37596483 | ||
| The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease | Q37695372 | ||
| Neurogenesis in Huntington's disease: can studying adult neurogenesis lead to the development of new therapeutic strategies? | Q37899578 | ||
| Integrins as receptor targets for neurological disorders | Q37974737 | ||
| Extracellular vesicles--Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases | Q38363970 | ||
| MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells. | Q38488736 | ||
| Micro RNA -214,-150,-146a and-125b target Huntingtin gene | Q39448940 | ||
| Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless | Q39753324 | ||
| Slowed progression in models of Huntington disease by adipose stem cell transplantation | Q39770706 | ||
| Circulating microRNAs in plasma of patients with gastric cancers | Q39986294 | ||
| miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche | Q42243673 | ||
| Abnormalities of neurogenesis in the R6/2 mouse model of Huntington's disease are attributable to the in vivo microenvironment. | Q42488000 | ||
| A microRNA-based gene dysregulation pathway in Huntington's disease | Q45307225 | ||
| Exosomes are released by cultured cortical neurones. | Q46918951 | ||
| Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor | Q48440531 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 45-52 | |
| P577 | publication date | 2017-01-18 | |
| P1433 | published in | Journal of movement disorders | Q26842217 |
| P1476 | title | Exosome-Based Delivery of miR-124 in a Huntington's Disease Model | |
| P478 | volume | 10 |
| Q92051086 | Advances in therapeutic applications of extracellular vesicles |
| Q60923218 | Blood exosomes as a tool for monitoring treatment efficacy and progression of neurodegenerative diseases |
| Q94464057 | Circulating Exosomal miRNA as Diagnostic Biomarkers of Neurodegenerative Diseases |
| Q47564897 | Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration |
| Q47986173 | Exosomal miR-7 Mediates Bystander Autophagy in Lung after Focal Brain Irradiation in Mice |
| Q90201702 | Exosomal miRNAs in central nervous system diseases: biomarkers, pathological mediators, protective factors and therapeutic agents |
| Q89909722 | Exosome-based small RNA delivery: Progress and prospects |
| Q92665254 | Exosomes released from neural progenitor cells and induced neural progenitor cells regulate neurogenesis through miR-21a |
| Q41605967 | Extracellular Vesicles in Brain Tumors and Neurodegenerative Diseases |
| Q98159114 | Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy |
| Q89494159 | MiR-124 and the Underlying Therapeutic Promise of Neurodegenerative Disorders |
| Q45304134 | Mutant Huntingtin Inhibits αB-Crystallin Expression and Impairs Exosome Secretion from Astrocytes |
| Q89910191 | Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances |
| Q64862636 | Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications |
| Q59132159 | Regenerative Approaches in Huntington's Disease: From Mechanistic Insights to Therapeutic Protocols |
| Q92257585 | The Potential Role of MicroRNA-124 in Cerebral Ischemia Injury |
| Q41949115 | The miR-124 family of microRNAs is crucial for regeneration of the brain and visual system in the planarian Schmidtea mediterranea |
Search more.